Xiaofan Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
Papers in
-
- Renal and related cancers 7
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
-
- Ferroptosis and cancer prognosis 7
- Renal cell carcinoma treatment 6
- Co-authors
- Fangrong Yan (40 shared papers)Yujie Zhou (15 shared papers)Jialin Meng (18 shared papers)Liyun Jiang (11 shared papers)Yang Wang (9 shared papers)Yue Zhu (6 shared papers)Xinjia Ruan (12 shared papers)Liya Zhang (6 shared papers)
- Journals
- Blood (2 papers)Cell Proliferation (2 papers)Nature Communications (2 papers)Critical Care (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaofan Lu
55 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 178
- Pulmonary and Respiratory Medicine 293
- Oncology 184
- Infectious Diseases 99
- Immunology 95
Countries citing papers authored by Xiaofan Lu
This map shows the geographic impact of Xiaofan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofan Lu more than expected).
Fields of papers citing papers by Xiaofan Lu
This network shows the impact of papers produced by Xiaofan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofan Lu. The network helps show where Xiaofan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 161 | |
| 2 | 2020 | 121 | |
| 3 | 2020 | 88 | |
| 4 | 2020 | 56 | |
| 5 | 2021 | 46 | |
| 6 | 2007 | 34 | |
| 7 | 1993 | 32 | |
| 8 | 2021 | 30 | |
| 9 | 2020 | 28 | |
| 10 | 2018 | 27 | |
| 11 | 2023 | 25 | |
| 12 | 2020 | 25 | |
| 13 | 2018 | 24 | |
| 14 | 2018 | 23 | |
| 15 | 2022 | 23 | |
| 16 | 2020 | 20 | |
| 17 | 2011 | 18 | |
| 18 | 2021 | 17 | |
| 19 | 2020 | 17 | |
| 20 | 2021 | 16 |
About Xiaofan Lu
Xiaofan Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 63 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Ferroptosis and cancer prognosis (7 papers), Renal cell carcinoma treatment (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA modifications and cancer (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (178 citations), Pulmonary and Respiratory Medicine (293 citations), Oncology (184 citations), Infectious Diseases (99 citations) and Immunology (95 citations). Xiaofan Lu has collaborated with scholars based in China, United States and France. Frequent co-authors include Fangrong Yan, Yujie Zhou, Jialin Meng, Liyun Jiang, Yang Wang, Yue Zhu, Xinjia Ruan, Liya Zhang, Jun Wang and Taige Chen. Their work appears in journals such as Blood, Cell Proliferation, Nature Communications, Critical Care and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.